From morphological resection to biological benefits: decision and reflection in the treatment of pancreatic adenocarcinoma
10.3760/cma.j.issn.1673-9752.2018.07.003
- VernacularTitle:从形态学根治到生物学获益:胰腺癌治疗的抉择与思考
- Author:
Yi MIAO
1
;
Zipeng LU
;
Min TU
Author Information
1. 210029,南京医科大学第一附属医院胰腺中心胰腺研究所
- Keywords:
Pancreas;
Neoplasms;
Morphology;
Biology
- From:
Chinese Journal of Digestive Surgery
2018;17(7):653-658
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic adenocarcinoma (PAC) is a highly lethal disease for human being.Surgery in the past 100 years,novel drug combination and neoadjuvant therapy haven't changed the prognosis of PAC fundamentally.Traditionally,authors only focused on the treatment in term of morphological changes,while it's tumor biology that will ultimately determine the long-term survival of PAC patients.Surgeons should continuously pursue the radical resection of pancreatic cancer,however,with the guidance of tumor biology.Omics' researches,artificial intelligence and next generation platform of translational study will improve our understanding and treatment for PAC.
